Management of Fibromyalgia
- 1 January 2002
- journal article
- review article
- Published by Springer Science and Business Media LLC in Drugs
- Vol. 62 (4), 577-592
- https://doi.org/10.2165/00003495-200262040-00003
Abstract
Fibromyalgia still represents an enigma to modern medicine and the aetiopathogenesis is far from explored. The management of patients with fibromyalgia is thus mostly based on empirical research, and only a few controlled studies have been performed. Basic drug therapy rests on the administration of amitriptyline and conventional analgesics. Such therapy should be initiated only after careful patient information and delineation of therapeutic goals are provided. Any drug therapy should be administered in combination with physical treatment and cognitive behavioural therapy. Because of the appearing contours of pathogenic mechanisms, hopefully a number of new drugs will be available to the patients with this complex pain syndrome in the near future.Keywords
This publication has 112 references indexed in Scilit:
- The association between fibromyalgia and carpal tunnel syndrome in the general population.Annals Of The Rheumatic Diseases, 1996
- Management strategies for chronic pain.Annals Of The Rheumatic Diseases, 1996
- Comparison of tenoxicam and bromazepan in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled trialPain, 1996
- The prevalence and characteristics of fibromyalgia in the general populationArthritis & Rheumatism, 1995
- Pathogenesis of Fibromyalgia:Journal of Musculoskeletal Pain, 1994
- PATHOLOGY OF SKELETAL MUSCLE IN FIBROMYALGIA: A HISTO-IMMUNO-CHEMICAL AND ULTRASTRUCTURAL STUDYRheumatology, 1993
- Treatment of primary fibrositis/fibromyalgia syndrome with ibuprofen and alprazolam. A double‐blind, placebo‐controlled studyArthritis & Rheumatism, 1991
- The american college of rheumatology 1990 criteria for the classification of fibromyalgiaArthritis & Rheumatism, 1990
- Treatment of fibromyalgia (Fibrositis syndrome): A parallel double blind trial with carisoprodol, paracetamol and caffeïne (Somadril comp®) versus placeboClinical Rheumatology, 1989
- The disability determination dilemma: Toward a multiaxial solutionPain, 1988